3.26.1 html 200 257 1 true 54 0 false 5 false false R1.htm 995300 - Document - Document and Entity Information Sheet http://adialpharma.com/20260630/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false R2.htm 995301 - Statement - Condensed Consolidated Balance Sheets (Unaudited) Sheet http://adialpharma.com/20260630/role/CondensedConsolidatedBalanceSheetsUnaudited Condensed Consolidated Balance Sheets (Unaudited) Statements 2 false false R3.htm 995302 - Statement - Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Sheet http://adialpharma.com/20260630/role/CondensedConsolidatedBalanceSheetsUnauditedParentheticals Condensed Consolidated Balance Sheets (Unaudited) (Parentheticals) Statements 3 false false R4.htm 995303 - Statement - Condensed Consolidated Statements of Operations (Unaudited) Sheet http://adialpharma.com/20260630/role/CondensedConsolidatedStatementsofOperationsUnaudited Condensed Consolidated Statements of Operations (Unaudited) Statements 4 false false R5.htm 995304 - Statement - Condensed Consolidated Statements of Temporary Equity and Stockholders’ (Deficit) Equity (Unaudited) Sheet http://adialpharma.com/20260630/role/CondensedConsolidatedStatementsofTemporaryEquityandStockholdersDeficitEquityUnaudited Condensed Consolidated Statements of Temporary Equity and Stockholders’ (Deficit) Equity (Unaudited) Statements 5 false false R6.htm 995305 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://adialpharma.com/20260630/role/CondensedConsolidatedStatementsofCashFlowsUnaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 995306 - Disclosure - Description of Business Sheet http://adialpharma.com/20260630/role/DescriptionofBusiness Description of Business Notes 7 false false R8.htm 995307 - Disclosure - Going Concern and Other Uncertainties Sheet http://adialpharma.com/20260630/role/GoingConcernandOtherUncertainties Going Concern and Other Uncertainties Notes 8 false false R9.htm 995308 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies Sheet http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPolicies Basis of Presentation and Summary of Significant Accounting Policies Notes 9 false false R10.htm 995309 - Disclosure - Acquisition of Azora and Pipe Issuance Sheet http://adialpharma.com/20260630/role/AcquisitionofAzoraandPipeIssuance Acquisition of Azora and Pipe Issuance Notes 10 false false R11.htm 995310 - Disclosure - Fair Value Measurements Sheet http://adialpharma.com/20260630/role/FairValueMeasurements Fair Value Measurements Notes 11 false false R12.htm 995311 - Disclosure - Equity Method Investments Sheet http://adialpharma.com/20260630/role/EquityMethodInvestments Equity Method Investments Notes 12 false false R13.htm 995312 - Disclosure - Accrued Expenses Sheet http://adialpharma.com/20260630/role/AccruedExpenses Accrued Expenses Notes 13 false false R14.htm 995313 - Disclosure - Convertible Preferred Stock Sheet http://adialpharma.com/20260630/role/ConvertiblePreferredStock Convertible Preferred Stock Notes 14 false false R15.htm 995314 - Disclosure - Stockholders' Equity Sheet http://adialpharma.com/20260630/role/StockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 995315 - Disclosure - Commitments and Contingencies Sheet http://adialpharma.com/20260630/role/CommitmentsandContingencies Commitments and Contingencies Notes 16 false false R17.htm 995316 - Disclosure - Segment Reporting Sheet http://adialpharma.com/20260630/role/SegmentReporting Segment Reporting Notes 17 false false R18.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 18 false false R19.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 19 false false R20.htm 996317 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Policies) Sheet http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesPolicies Basis of Presentation and Summary of Significant Accounting Policies (Policies) Policies http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPolicies 20 false false R21.htm 996318 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Tables) Sheet http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables Basis of Presentation and Summary of Significant Accounting Policies (Tables) Tables http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPolicies 21 false false R22.htm 996319 - Disclosure - Acquisition of Azora and Pipe Issuance (Tables) Sheet http://adialpharma.com/20260630/role/AcquisitionofAzoraandPipeIssuanceTables Acquisition of Azora and Pipe Issuance (Tables) Tables http://adialpharma.com/20260630/role/AcquisitionofAzoraandPipeIssuance 22 false false R23.htm 996320 - Disclosure - Fair Value Measurements (Tables) Sheet http://adialpharma.com/20260630/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://adialpharma.com/20260630/role/FairValueMeasurements 23 false false R24.htm 996321 - Disclosure - Equity Method Investments (Tables) Sheet http://adialpharma.com/20260630/role/EquityMethodInvestmentsTables Equity Method Investments (Tables) Tables http://adialpharma.com/20260630/role/EquityMethodInvestments 24 false false R25.htm 996322 - Disclosure - Accrued Expenses (Tables) Sheet http://adialpharma.com/20260630/role/AccruedExpensesTables Accrued Expenses (Tables) Tables http://adialpharma.com/20260630/role/AccruedExpenses 25 false false R26.htm 996323 - Disclosure - Stockholders' Equity (Tables) Sheet http://adialpharma.com/20260630/role/StockholdersEquityTables Stockholders' Equity (Tables) Tables http://adialpharma.com/20260630/role/StockholdersEquity 26 false false R27.htm 996324 - Disclosure - Segment Reporting (Tables) Sheet http://adialpharma.com/20260630/role/SegmentReportingTables Segment Reporting (Tables) Tables http://adialpharma.com/20260630/role/SegmentReporting 27 false false R28.htm 996325 - Disclosure - Description of Business (Details) Sheet http://adialpharma.com/20260630/role/DescriptionofBusinessDetails Description of Business (Details) Details http://adialpharma.com/20260630/role/DescriptionofBusiness 28 false false R29.htm 996326 - Disclosure - Going Concern and Other Uncertainties (Details) Sheet http://adialpharma.com/20260630/role/GoingConcernandOtherUncertaintiesDetails Going Concern and Other Uncertainties (Details) Details http://adialpharma.com/20260630/role/GoingConcernandOtherUncertainties 29 false false R30.htm 996327 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies (Details) Sheet http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesDetails Basis of Presentation and Summary of Significant Accounting Policies (Details) Details http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesTables 30 false false R31.htm 996328 - Disclosure - Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Common Shares (Details) Sheet http://adialpharma.com/20260630/role/BasisofPresentationandSummaryofSignificantAccountingPoliciesScheduleofPotentiallyDilutiveCommonSharesDetails Basis of Presentation and Summary of Significant Accounting Policies - Schedule of Potentially Dilutive Common Shares (Details) Details 31 false false R32.htm 996329 - Disclosure - Acquisition of Azora and Pipe Issuance - (Details) Sheet http://adialpharma.com/20260630/role/AcquisitionofAzoraandPipeIssuanceDetails Acquisition of Azora and Pipe Issuance - (Details) Details http://adialpharma.com/20260630/role/AcquisitionofAzoraandPipeIssuanceTables 32 false false R33.htm 996330 - Disclosure - Acquisition of Azora and Pipe Issuance - Schedule of Fair Value of Consideration Transferred (Details) Sheet http://adialpharma.com/20260630/role/AcquisitionofAzoraandPipeIssuanceScheduleofFairValueofConsiderationTransferredDetails Acquisition of Azora and Pipe Issuance - Schedule of Fair Value of Consideration Transferred (Details) Details 33 false false R34.htm 996331 - Disclosure - Acquisition of Azora and Pipe Issuance - Schedule of Allocation to Estimated Fair Value of Consideration Transferred to Net Assets (Details) Sheet http://adialpharma.com/20260630/role/AcquisitionofAzoraandPipeIssuanceScheduleofAllocationtoEstimatedFairValueofConsiderationTransferredtoNetAssetsDetails Acquisition of Azora and Pipe Issuance - Schedule of Allocation to Estimated Fair Value of Consideration Transferred to Net Assets (Details) Details 34 false false R35.htm 996332 - Disclosure - Fair Value Measurements (Details) Sheet http://adialpharma.com/20260630/role/FairValueMeasurementsDetails Fair Value Measurements (Details) Details http://adialpharma.com/20260630/role/FairValueMeasurementsTables 35 false false R36.htm 996333 - Disclosure - Fair Value Measurements - Schedule of Fair Value of the Milestone Warrant Liability (Details) Sheet http://adialpharma.com/20260630/role/FairValueMeasurementsScheduleofFairValueoftheMilestoneWarrantLiabilityDetails Fair Value Measurements - Schedule of Fair Value of the Milestone Warrant Liability (Details) Details 36 false false R37.htm 996334 - Disclosure - Fair Value Measurements - Schedule of Milestone Warrant Liability (Details) Sheet http://adialpharma.com/20260630/role/FairValueMeasurementsScheduleofMilestoneWarrantLiabilityDetails Fair Value Measurements - Schedule of Milestone Warrant Liability (Details) Details 37 false false R38.htm 996335 - Disclosure - Equity Method Investments (Details) Sheet http://adialpharma.com/20260630/role/EquityMethodInvestmentsDetails Equity Method Investments (Details) Details http://adialpharma.com/20260630/role/EquityMethodInvestmentsTables 38 false false R39.htm 996336 - Disclosure - Equity Method Investments - Schedule of Equity Method Investment (Details) Sheet http://adialpharma.com/20260630/role/EquityMethodInvestmentsScheduleofEquityMethodInvestmentDetails Equity Method Investments - Schedule of Equity Method Investment (Details) Details 39 false false R40.htm 996337 - Disclosure - Accrued Expenses (Details) Sheet http://adialpharma.com/20260630/role/AccruedExpensesDetails Accrued Expenses (Details) Details http://adialpharma.com/20260630/role/AccruedExpensesTables 40 false false R41.htm 996338 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details) Sheet http://adialpharma.com/20260630/role/AccruedExpensesScheduleofAccruedExpensesDetails Accrued Expenses - Schedule of Accrued Expenses (Details) Details 41 false false R42.htm 996339 - Disclosure - Convertible Preferred Stock (Details) Sheet http://adialpharma.com/20260630/role/ConvertiblePreferredStockDetails Convertible Preferred Stock (Details) Details http://adialpharma.com/20260630/role/ConvertiblePreferredStock 42 false false R43.htm 996340 - Disclosure - Stockholders' Equity (Details) Sheet http://adialpharma.com/20260630/role/StockholdersEquityDetails Stockholders' Equity (Details) Details http://adialpharma.com/20260630/role/StockholdersEquityTables 43 false false R44.htm 996341 - Disclosure - Stockholders' Equity -Schedule of Stock Option Activity (Details) Sheet http://adialpharma.com/20260630/role/StockholdersEquityScheduleofStockOptionActivityDetails Stockholders' Equity -Schedule of Stock Option Activity (Details) Details 44 false false R45.htm 996342 - Disclosure - Stockholders' Equity - Schedule of Black Scholes Valuation Model to Determine the Fair Value of the Options Issued (Details) Sheet http://adialpharma.com/20260630/role/StockholdersEquityScheduleofBlackScholesValuationModeltoDeterminetheFairValueoftheOptionsIssuedDetails Stockholders' Equity - Schedule of Black Scholes Valuation Model to Determine the Fair Value of the Options Issued (Details) Details 45 false false R46.htm 996343 - Disclosure - Stockholders' Equity - Schedule of Stock-Based Compensation Expense (Details) Sheet http://adialpharma.com/20260630/role/StockholdersEquityScheduleofStockBasedCompensationExpenseDetails Stockholders' Equity - Schedule of Stock-Based Compensation Expense (Details) Details 46 false false R47.htm 996344 - Disclosure - Stockholders' Equity - Schedule of Restricted Stock Units (Details) Sheet http://adialpharma.com/20260630/role/StockholdersEquityScheduleofRestrictedStockUnitsDetails Stockholders' Equity - Schedule of Restricted Stock Units (Details) Details 47 false false R48.htm 996345 - Disclosure - Stockholders' Equity - Schedule of Activity in Warrants (Details) Sheet http://adialpharma.com/20260630/role/StockholdersEquityScheduleofActivityinWarrantsDetails Stockholders' Equity - Schedule of Activity in Warrants (Details) Details 48 false false R49.htm 996346 - Disclosure - Commitments and Contingencies (Details) Sheet http://adialpharma.com/20260630/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://adialpharma.com/20260630/role/CommitmentsandContingencies 49 false false R50.htm 996347 - Disclosure - Segment Reporting (Details) Sheet http://adialpharma.com/20260630/role/SegmentReportingDetails Segment Reporting (Details) Details http://adialpharma.com/20260630/role/SegmentReportingTables 50 false false R51.htm 996348 - Disclosure - Segment Reporting - Schedule of Significant Segment Expenses (Details) Sheet http://adialpharma.com/20260630/role/SegmentReportingScheduleofSignificantSegmentExpensesDetails Segment Reporting - Schedule of Significant Segment Expenses (Details) Details 51 false false All Reports Book All Reports adil-20260630.xsd adil-20260630_cal.xml adil-20260630_def.xml adil-20260630_lab.xml adil-20260630_pre.xml ea0301265-10q_adial.htm ea030126501_img1.jpg ea030126501_img2.jpg ea030126501_img3.jpg ea030126501_img4.jpg ea030126501_img5.jpg ea030126501_img6.jpg ea030126501_img7.jpg ea030126501_img8.jpg ea030126501_img9.jpg http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 true true